Gauri Kiefer

Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

Joanna M. Brell, Khalid Matin, Terry Evans et al. · Oncology · 2009 · 34 citations

Medicine, Oncology, Pharmacotherapy +15

A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas

Shelly S. Lo, Alok A. Khorana, Milind Javle et al. · Oncology · 2010 · 19 citations

Medicine, Oncology, Pharmacology +14

Patient, family caregiver, and economic outcomes of an integrated screening and novel stepped collaborative care intervention in the oncology setting in the USA (CARES): a randomised, parallel, phase 3 trial

Jennifer L. Steel, Charles J. George, Lauren Terhorst et al. · The Lancet · 2024 · 19 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

Phase II study of rubitecan, an oral camptothecin in patients with advanced colorectal cancer who have failed previous 5-fluorouracil based chemotherapy

Hitendra Patel, Ronald G. Stoller, Miklos Auber et al. · Investigational New Drugs · 2006 · 11 citations

Medicine, Oncology, Pharmacology +15

SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)

Hossein Borghaei, Mary W. Redman, Karen Kelly et al. · Clinical Lung Cancer · 2020 · 11 citations · Full text

Medicine, Oncology, Chemotherapy +10